Press release issued on October 2, 2017

PoCOsteo: a new European effort targeting early-stage osteoporosis detection

Ghent University and its project partners today announced the launch of the PoCOsteo project. Together they will develop and validate a point-of-care in-office device for identifying individuals at high risk of osteoporosis and osteoporotic fracture. The project is supported by the European Union’s Horizon 2020 Framework Programme for Industrial leadership in nanotechnologies, advanced materials, biotechnology and advanced manufacturing and processing (H2020-NMBP). The overall goal of the project is the development, clinical validation and preparation for commercialisation of a point-of-care tool for bone disease (a.o. osteoporosis) prevention, detection and treatment.

Indeed, as a consequence of the ageing of the society, osteoporosis (literally “porous bone”) and its complications is becoming more and more prevalent, making the bone disease a health priority in many parts of the world. Usually osteoporosis manifests itself in a drastic manner, i.e. through fracture of the osteoporotic bone in the affected individual. This causes a serious burden for the patient and a high medical care cost for the society. Currently osteoporosis is commonly known as a “silent killer” disease. Up to 20% of patients die in the first year following a hip fracture, mostly due to pre-existing medical conditions. Less than half of those who survive the hip fracture regain their previous level of function [1]. Early detection of individuals at risk of osteoporosis and starting a suitable treatment before fractures and complications arise would drastically improve the current situation. Until now little or no measures for prevention or early detection of osteoporosis are taken, because no simple, yet sufficiently accurate or sensitive tools for early detection are available.

The PoCOsteo system will employ electrochemical detection and brings together proteomics, genomics and microfluidics technologies. The in-office test will provide the results in real-time during consultation and can be performed by unskilled technicians even at rural areas where access to current state-of-the-art equipment is limited. The design will limit the amount of both expensive reagents and blood samples needed for the tests and so it not only reduces the cost of each test, which is of great importance, especially nowadays when full reimbursement is not practiced in many countries, but also reduces the patient’s pain and discomfort.

The project will be supported and advised by the IOF, the International Osteoporosis Foundation, which is the main global alliance of patient societies, research organizations, healthcare professionals and international companies working to promote bone, muscle and joint health.

Over the next four years, PoCOsteo will be coordinated by Ghent University. Industrial, academic and clinical partners will bring their expertise to the project: Universitat Rovira I Virgili and microLIQUID (Spain), Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung (Germany), Labman Automation (United Kingdom), Medizinische Universität Graz (Austria),  Endocrinology and Metabolism Research Institute (Iran) and Fundico (Belgium).

Source of information

2018-01-30T15:13:16+00:00

By using the PoCOsteo site, you are consenting to our use of cookies in accordance with our Cookie Policy. more information

The cookie-settings on this website our set to "accept cookies" to give you the best surfing experience possible. If you continue to use this website without changing your cookie-settings or if you click "Accept" here under then you are accepting these settings.

What are cookies?
Cookies are files or pieces of information that may be stored on your computer (or other internet enabled devices, such as a smartphone or tablet) when you visit a Site. A cookie will usually contain the name of the website from which the cookie has come from, the "lifetime" of the cookie (i.e. how long it will remain on your device), and a value, which is usually a randomly generated unique number.

What do we use cookies for?
We use cookies to make the PoCOsteo Site easier to use and to better tailor the PoCOsteo Site to your interests and needs. Cookies may also be used to help speed up your future activities and experience on our Site. We also use cookies to compile anonymous, aggregated statistics that allow us to understand how people use our Site and to help us improve the structure and content. We cannot identify you personally from this information.

What kind of cookies do we use?
Two types of cookies may be used - "session cookies" and "persistent cookies". Session cookies are temporary cookies that remain on your device until you leave the Site. A persistent cookie remains on your device for much longer or until you manually delete it (how long the cookie remains on your device will depend on the duration or "lifetime" of the specific cookie and your browser settings).

Do we use third party cookies?
We use a number of suppliers that may also set cookies on your device on our behalf when you visit the PoCOsteo Site to allow them to deliver the services they are providing. When you visit the Site you may receive cookies from third party websites or domains.

How can I control or delete cookies?
Most internet browsers are initially set up to automatically accept cookies. You can change the settings to block cookies or to alert you when cookies are being sent to your device. There are a number of ways to manage cookies. Please refer to your browser instructions or help screen to learn more about how to adjust or modify your browser settings. If you disable the cookies that we use, this may impact your experience while on the PoCOsteo Site, for example you may not be able to visit certain areas of the Site.

If you use different devices to view and access the Sites (e.g. your computer, smartphone, tablet etc) you will need to ensure that each browser on each device is adjusted to suit your cookie preferences.

Close